Pharmaceutical manufacturers are facing the need to add unique serial numbers to their drug packages in a growing list of countries around the world, including China, Turkey, Brazil, Argentina, South Korea, and in the European Union. Even drug manufacturers that only sell their products in the U.S. are faced with the need to do the same in at least the state of California. Have these facts led every company to begin the process of converting their packaging lines to add global serialization capabilities? until Healthcare Packaging conducted its survey (pwgo.to/065), no one really knew the answer to this and a whole host of other compelling questions.
展开▼
